![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EUROCOR GMBH RECEIVES CE MARK APPROVAL FOR TAXCOR I
EUROCOR GMBH RECEIVES CE MARK APPROVAL FOR TAXCOR I
July 10, 2006
Eurocor Gmbh an Opto Circuits company has received CE mark approval of its new polymer-free, TAXCOR I.Paclitaxel-eluting coronary stent system. Though polymer-free, this innovative
drug-eluting stent technology eliminates any polymer-related, late adverse effect
potential for the patient, like subacute thrombosis.
My
Iris
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct